Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesEndocrinologyFlorida Blue CGM Prior Auth Policy Update | OpenPa…
    Ask Trek AI about this page
    CurrentFlorida BluePolicy N/A

    Prior authorization policy for preferred continuous glucose monitors (CGMs) and supplies

    Customize your policy alerts

    Sign up for all Florida Blue policy alerts

    Know when Florida Blue releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    BlueMedicare HMO and PPO Medicare Advantage patients may obtain preferred CGMs (Dexcom and FreeStyle Libre) and supplies without prior authorization; non-preferred/adjunctive CGMs still require authorization. Applies to Part B coverage channels noted in the document.

    Policy Summary
    PayerFlorida Blue
    PolicyPrior authorization policy for preferred continuous glucose monitors (CGMs) and supplies
    Policy CodePolicy N/A
    Change TypeMaterial update (preferred CGMs no longer require prior authorization)
    Effective DateJan 1, 2024
    Next Review DateN/A
    Key ActionSend a prescription for the CGM and maintenance supplies to the patient's in-network retail or home delivery pharmacy and document adherence with a visit every 6 months.
    SourceLink
    POLICY UPDATE CHANGES

    Preferred continuous glucose monitors (Dexcom and FreeStyle Libre) and supplies for BlueMedicare HMO and PPO patients no longer require prior authorization beginning January 1, 2024.

    Prior authorization remains required for non-preferred adjunctive CGMs (e.g., Guardian) and related supplies.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    2 brands
    Preferred CGMs no PA
    GuardianNon-preferred CGMs require PA
    Part BBenefit
    Every 6 monthsFollow-up

    Coverage Criteria for Continuous Glucose Monitors

    Preferred continuous glucose monitors (CGMs) for BlueMedicare HMO and PPO beneficiaries are the Dexcom and FreeStyle Libre product families. When the patient meets CMS eligibility (treated with insulin or meets CMS hypoglycemia event thresholds) and the prescriber sends a prescription for the CGM and maintenance supplies to an in-network retail or home delivery pharmacy, these preferred CGMs and their supplies do not require prior authorization. Preferred products may be obtained from local in-network retail pharmacies or via home delivery (mail-order) pharmacy per the payer's distribution options.

    Non-preferred CGMs, described as adjunctive CGMs (examples include Guardian devices), remain subject to the payer's prior authorization process and are not in the preferred/no-prior-authorization category. Once a non-preferred adjunctive CGM is authorized, the prescription and maintenance supplies should be sent to the member's chosen in-network retail or home delivery pharmacy.

    This policy does not present a separate list of clinical scenarios labeled explicitly as “not medically necessary.” Instead, the document distinguishes products by administrative coverage pathway: specified preferred CGMs (Dexcom and FreeStyle Libre) are afforded an administrative exception to prior authorization, while other CGMs not on that preferred list are managed through the payer’s prior authorization requirements and submission workflows.

    As a practical matter, absence of a ‘not medically necessary’ label means clinical eligibility follows CMS criteria for Part B CGM coverage; administrative access (no prior authorization vs. prior authorization required) is determined by whether the device is on the payer’s preferred list.

    Coding and Product Identifiers

    Preferred CGMs (No Prior Authorization Required) — sample NDCsNDCCovered
    08627003011DEXCOM G4 PLATINUM PEDIATRIC RECEIVER KIT
    08627003021DEXCOM G4 PLATINUM PEDIATRIC RECEIVER KIT
    08627003031DEXCOM G4 PLATINUM PEDIATRIC RECEIVER KIT
    08627006011DEXCOM G4 PLATINUM PEDIATRIC RECEIVER KITISHARE
    08627006021DEXCOM G4 PLATINUM PEDIATRIC RECEIVER KITISHARE
    08627006031DEXCOM G4 PLATINUM PEDIATRIC RECEIVER KITISHARE
    08627002011DEXCOM G4 PLATINUM RECEIVER KIT
    08627002021DEXCOM G4 PLATINUM RECEIVER KIT
    08627002031DEXCOM G4 PLATINUM RECEIVER KIT
    08627005104DEXCOM G5 MOBILEIG4 PLATINUM SENSOR KIT
    1–10 of 20
    1/2
    Non-preferred / adjunctive CGMs (examples — prior authorization required)NDCNot Covered
    63000041338GUARDIAN 4 GLUCOSE SENSOR
    63000051968GUARDIAN 4 GLUCOSE SENSOR
    63000044515GUARDIAN 4 TRANSMITTER KIT
    63000044516GUARDIAN 4 TRANSMITTER KIT
    43169095568GUARDIAN LINK 3 TRANSMITTER KIT
    76300000805ENLITE GLUCOSE SENSOR
    76300010001GUARDIAN REAL-TIME REPLACEMENT MONITOR
    Hypoglycemia event thresholds (CMS)
    CMS hypoglycemia level 2 thresholdTwo or more level 2 hypoglycemic events (glucose <54 mg/dL) that persist despite multiple modifications to the treatment or medication plan.
    CMS hypoglycemia level 3 thresholdOne level 3 hypoglycemic event (glucose <54 mg/dL) characterized by altered mental and/or physical state requiring third‑party assistance for treatment.
    Documentation frequency after initial prescriptionTreating practitioner must conduct an in‑person or Medicare‑approved telehealth visit every six months to document adherence to the CGM regimen and diabetes treatment plan.

    Provider Actions and Prior Authorization Workflow

    Prior Authorization

    Prior authorization requirement

    Preferred CGMs (Dexcom and FreeStyle Libre) and their maintenance supplies do NOT require prior authorization for BlueMedicare HMO and PPO patients effective 2024-01-01. Prescribers should send the CGM and supplies prescription to any in‑network retail pharmacy or home delivery (mail‑order) pharmacy of the patient’s choice. CMS coverage and documentation expectations (initial and six‑monthly follow‑up visits documenting adherence) still apply.

    • Applies to Dexcom and FreeStyle Libre preferred products and supplies
    • Obtainable from in‑network retail or home delivery pharmacy
    • CMS requires initial qualification and follow‑up every six months
    Denial Risk

    Non‑preferred CGM prior authorization requirement

    Requests for non‑preferred adjunctive CGMs (for example, Guardian products) require prior authorization and will continue to be submitted via Availity per the enhanced process implemented April 2023. Prior authorization may be denied if the authorization criteria are not met.

    Definitions and Eligibility

    CMS coverage criteria for CGM eligibility
    CMS eligibility categoriesPatients with diabetes treated with insulin OR patients with hypoglycemia meeting CMS event thresholds (see hypoglycemia thresholds).
    Preferred CGM coverage pathwayPreferred CGMs (Dexcom and FreeStyle Libre): prescriber sends prescription for CGM and maintenance supplies to the patient’s in‑network retail or home delivery pharmacy; no prior authorization required for BlueMedicare HMO and PPO patients when CMS eligibility is met.
    Non‑preferred/adjunctive CGM requirementNon‑preferred adjunctive CGMs (e.g., Guardian devices) require prior authorization; once authorized, prescription and supplies are sent to the patient’s in‑network pharmacy.
    Insulin pump exceptionWhen a non‑preferred adjunctive CGM is provided with an insulin pump at initial provision, authorization can be obtained through CareCentrix (per payer process).
    Non-preferred / adjunctive CGMs (examples include Guardian devices)

    Background

    Continuous glucose monitors (CGMs) are covered under Medicare Part B when CMS clinical eligibility is met. CMS-defined eligibility generally includes patients treated with insulin or patients who meet specified hypoglycemia event thresholds; providers must also perform follow-up visits to document adherence and the diabetes treatment plan at intervals noted in the policy.

    Florida Blue’s operational change effective January 1, 2024, makes selected CGM products and supplies more administratively accessible for BlueMedicare HMO and PPO members: preferred CGMs (Dexcom and FreeStyle Libre) and their supplies can be obtained without prior authorization from an in-network retail or home delivery pharmacy. However, non-preferred adjunctive CGMs (e.g., Guardian) continue to require prior authorization under the payer’s established processes. When an adjunctive CGM is initially provided with an insulin pump, authorization may be obtained through the payer’s designated channel (for example, CareCentrix) with subsequent refills supplied through in-network pharmacies during the approved authorization period.

    Revision History

    2024-01-01policy_effectiveLatest

    Preferred continuous glucose monitors (Dexcom and FreeStyle Libre) and related supplies for BlueMedicare HMO and PPO patients no longer require prior authorization effective January 1, 2024; these may be obtained from in-network retail or home delivery pharmacies.

    policy_clarification

    Prior authorization remains required for non-preferred adjunctive CGMs (for example, Guardian devices) and related supplies; these continue to be managed under the payer's existing authorization processes.

    Policy Summary
    PayerFlorida Blue
    PolicyPrior authorization policy for preferred continuous glucose monitors (CGMs) and supplies
    Policy CodePolicy N/A
    Change TypeMaterial update (preferred CGMs no longer require prior authorization)
    Effective DateJan 1, 2024
    Next Review DateN/A
    Key ActionSend a prescription for the CGM and maintenance supplies to the patient's in-network retail or home delivery pharmacy and document adherence with a visit every 6 months.
    SourceLink
    On This Page
    Coverage Criteria for Continuous Glucose MonitorsCoding and Product IdentifiersProvider Actions and Prior Authorization WorkflowDefinitions and EligibilityBackgroundRevision History
    • Non‑preferred = adjunctive CGMs (e.g., Guardian)
    • Submission via Availity — follow Availity instructions posted in the prior bulletin
    • Prior authorization required before dispensing; may be denied if criteria unmet
    Documentation Required

    Insulin pump with adjunctive CGM documentation flow

    When a non‑preferred adjunctive CGM is being provided together with an insulin pump, the initial authorization and first supply may be obtained through CareCentrix at the time the pump is provided. Subsequent CGM supply refills are dispensed through the patient’s participating in‑network retail or home delivery pharmacy and do NOT require a separate authorization during the approved authorization period.

    • Initial authorization and initial fill for adjunctive CGM bundled with insulin pump: CareCentrix pathway
    • Subsequent refills: in‑network retail or home delivery pharmacy — no additional authorization required during authorization period
    • Exception: follow local CareCentrix instructions for pump + CGM provision
    Step Therapy

    Step therapy / submission pathway

    Step therapy / submission pathway: non‑preferred adjunctive CGM prior authorization requests should be submitted through Availity using the streamlined prior authorization process. Providers must follow the Availity instructions for required documentation and clinical criteria; detailed submission guidance is available in the prior bulletin referenced by Florida Blue.

    • Submit non‑preferred adjunctive CGM (e.g., Guardian) PA requests via Availity
    • Include supporting clinical documentation per Availity/Florida Blue requirements
    • See prior bulletin for step‑by‑step submission instructions
    Documentation Required

    Prescription and follow-up documentation

    Prescription and follow‑up documentation: prescribers must send CGM and maintenance supply prescriptions to an in‑network retail or home delivery pharmacy. For CMS‑covered beneficiaries, document initial medical necessity and perform in‑person or CMS‑approved telehealth visits every six months to confirm adherence to the CGM regimen and diabetes treatment plan.

    • Send prescriptions to in‑network retail or home delivery pharmacy
    • Document initial qualification and keep six‑month follow‑up visit notes to support continued coverage
    • Follow CMS documentation standards for hypoglycemia events and insulin treatment status
    DefinitionNon‑preferred / adjunctive CGMs are devices not on the preferred list that require prior authorization and may be used adjunctively (examples include Guardian devices).
    Authorization requirementRequests for non‑preferred adjunctive CGMs must be submitted via the payer’s prior authorization process (Availity) and may be denied if authorization is not obtained.
    Post‑authorization provisioningOnce authorized, adjunctive CGMs and maintenance supplies should be sent to the beneficiary’s in‑network retail or home delivery pharmacy; for pump‑associated adjunctive CGMs, subsequent refills are supplied through in‑network pharmacies without additional authorization during the approved authorization period.